Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002634
What this trial is testing

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT06514534
What this trial is testing

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

Who this might be right for
Chronic Myeloid Leukemia (CML)
Novartis Pharmaceuticals 20
Post-approval studies (Phase 4)Study completedNCT03649334
What this trial is testing

Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy

Who this might be right for
Hematological Malignancy (Leukemia- Lymphoma)
Mansoura University 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05071209
What this trial is testing

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Alveolar RhabdomyosarcomaRecurrent Ewing SarcomaRecurrent Lymphoma+5 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Study completedNCT04416516
What this trial is testing

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Ascend Biopharmaceuticals Ltd 21
Testing effectiveness (Phase 2)Study completedNCT01098084
What this trial is testing

Decitabine in Patients With Chronic Myelomonocytic Leukemia (CMML)

Who this might be right for
Chronic Myelomonocytic Leukemia
Groupe Francophone des Myelodysplasies 41
Large-scale testing (Phase 3)Study completedNCT01460693
What this trial is testing

Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

Who this might be right for
Myeloid Leukemia, Chronic, Chronic Phase
Newcastle University 814
Testing effectiveness (Phase 2)Ended earlyNCT01548573
What this trial is testing

Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment

Who this might be right for
Multiple Myeloma
University of Iowa 19
Testing effectiveness (Phase 2)Study completedNCT01700673
What this trial is testing

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05873673
What this trial is testing

Coenzyme Q10 and Dentoalveolar Cyst

Who this might be right for
Cyst, Jaw
Fayoum University 20
Not applicableNot Yet RecruitingNCT06022341
What this trial is testing

MultiOmic characteriZation of Acute Myeloid Leukemia Evolving From myelopRoliferative Neoplasm to Identify New Targeted Therapeutic Strategies

Who this might be right for
Myeloproliferative NeoplasmSecondary Leukemia
University Hospital, Angers 120
Testing effectiveness (Phase 2)Study completedNCT00001873
What this trial is testing

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic Neoplasm+2 more
National Heart, Lung, and Blood Institute (NHLBI) 102
Not applicableStudy completedNCT02618369
What this trial is testing

MR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and Adults

Who this might be right for
Osteoid OsteomaBenign Bone TumorPain
The Hospital for Sick Children 10
Large-scale testing (Phase 3)Ended earlyNCT01650805
What this trial is testing

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

Who this might be right for
Chronic Myeloid Leukemia
Ariad Pharmaceuticals 307
Large-scale testing (Phase 3)Active Not RecruitingNCT00572169
What this trial is testing

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 177
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Early research (Phase 1)Study completedNCT02367456
What this trial is testing

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Pfizer 73
Testing effectiveness (Phase 2)Looking for participantsNCT06566742
What this trial is testing

Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaClonal Cytopenia of Undetermined Significance
M.D. Anderson Cancer Center 15
Not applicableLooking for participantsNCT06243588
What this trial is testing

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Istituto Ortopedico Rizzoli 400
Early research (Phase 1)Study completedNCT00275080
What this trial is testing

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more
National Cancer Institute (NCI) 80
Next Page